Acta obstetricia et gynecologica Scandinavica
-
Acta Obstet Gynecol Scand · May 2001
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialThe oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
To compare the efficacy and safety of atosiban and terbutaline for the inhibition of preterm labor. ⋯ The efficacy of atosiban in the inhibition of preterm labor was shown to be comparable to terbutaline. Atosiban had a superior safety profile compared with terbutaline in terms of maternal and fetal adverse events, and comparable infant outcomes.